Re: Wells Et Al.: Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results From a Comparative Effectiveness Randomized Clinical Trial (Ophthalmology 2016;123:1351-1359)
Ophthalmology - Netherlands
doi 10.1016/j.ophtha.2016.03.052
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2017
Authors
Publisher
Elsevier BV